Skip to content
Research Article Open access CC BY 4.0

Seroprevalence and Risk Factors of Toxoplasmosis among Pregnant Women Attending Antenatal Clinic in Kaduna Metropolis and Environs

Halima Sadia Bello, Yahaya Abdullahi Umar, M. S. Abdulsalami, Victor Oluwasanmi Amusan

International Journal of TROPICAL DISEASE & Health · pp. 1–11 · Published 18 May 2017

10.9734/IJTDH/2017/33528

Abstract

Toxoplasmosis due to infection by Toxoplasma gondii is estimated to affect one third of the global population. In pregnancy, T. gondii infection represents the risk to induce miscarriage and congenital transmission. This study was therefore conducted to determine the seroprevalence of anti-T. gondii IgM antibodies among pregnant women attending antenatal clinics in Kaduna south, Nigeria. Enzyme-linked immunosorbent assay (ELISA) was used and structured questionnaire to obtain information on risk factors associated with infection among pregnant women attending antenatal clinics at Gwamna Awam General Hospital Kakuri and Yusuf Dantsoho Memorial Hospital Tudun Wada in Kaduna State. A total of One hundred and ninety two (192) blood samples (96 from each of the selected hospital) were collected from the pregnant women and screened using specific anti-Toxoplasma gondii IgM antibodies kit (IBL- International GMBH a Tecan Group Company). Result obtained from the 192 women serum analysed showed an overall seroprevalence of 31.3% using T. gondii specific IgM antibodies. Seropositivity was found to be statistically associated with age (P < 0.05) while Relative Risk  (RR) analysis showed that women aged between 31-35 yrs. were found to have higher risk of contracting toxoplasmosis than all other age groups (RR 4.620). Chi-Square test showed that pregnancy stages, previous history of miscarriage and educational level of pregnant women were found to significantly influence prevalence of T. gondii infection (P < 0.05). Women with previous history of miscarriage was found to be more likely to be infected with toxoplasmosis than women with no history of miscarriage (RR= 1.278). Risk factor such as keeping cats was found to significantly influence Toxoplasma infection among the sampled women. The results of this study justifies the need to include laboratory testing for T. gondii infection during antenatal investigations and to educate women about the parasite in order to prevent maternal and subsequent congenital infections that might have been provoked in-utero.

Toxoplasma gondii seroprevalence antibodies risk factors pregnant women.

References (19)

  1. 1 Bulletin of the World Health Organization
  2. 2 THE JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY [DOI]
  3. 3 Toxoplasmosis of Animals and Man [DOI]
  4. 4 The global burden of congenital toxoplasmosis: a systematic review [DOI]
  5. 5 Toxoplasmosis – a waterborne zoonosis [DOI]
  6. 6 Lytic Cycle ofToxoplasma gondii [DOI]
  7. 7 Selective Evolution of Stromal Mesenchyme with p53 Loss in Response to Epithelial Tumorigenesis [DOI]
  8. 8 Risk factors for Toxoplasma gondii infection in mothers of infants with congenital toxoplasmosis: Implications for prenatal management and screening [DOI]
  9. 9 False-positive results in immunoglobulin M (IgM) toxoplasma antibody tests and importance of confirmatory testing: the Platelia Toxo IgM test [DOI]
  10. 10 Toxoplasmosis as a cause for behaviour disorders - overview of evidence and mechanisms [DOI]
  11. 11 19A Antibodies for Diagnosis of Acute Congenital and Acquired Toxoplasmosis [DOI]
  12. 12 Correlation of duration of latent Toxoplasma gondii infection with personality changes in women [DOI]
  13. 13 The seroprevalence of antibodies to Toxoplasma gondii in domestic goats in Uganda [DOI]
  14. 14 Seroepidemiological study of toxoplasma gondii infection in the human population in the Eastern Region [DOI]
  15. 15 The seroprevalence of toxoplasmosis in pigs in Ghana [DOI]
  16. 16 Evaluation of a real-time polymerase chain reaction assay for the detection of Dientamoeba fragilis [DOI]
  17. 17 Marked variation in pyrimethamine disposition in AIDS patients treated for cerebral toxoplasmosis [DOI]
  18. 18 Protozoan infections in humans: congenital toxoplasmosis [DOI]
  19. 19 Gynecologic and Obstetric Investigation [DOI]

Cited by 5

Showing 1 of 5 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

28

Page views

0

PDF downloads

4

Outbound clicks

5

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.